Companies

CRISPR Therapeutics

CRISPR Therapeutics develops gene-based medicines using CRISPR/Cas9 editing, co-founded on foundational work by Emmanuelle Charpentier. Its lead therapy for sickle cell disease emerged from research partnerships spanning ETH Zurich and leading hematology centers.

Details

Industry

Biotech

R&D Spend

$0.7B